Home > 業績・特許・研究費 > 論文 > Safe and low-dose but therapeutically effective adenovirus-mediated hepatocyte growth factor gene therapyfor type 1 diabetes in mice.
Eriko Matsuda,Yuki Obama,Ken-ichiro Kosai
Safe and low-dose but therapeutically effective adenovirus-mediated hepatocyte
growth factor gene therapyfor type 1 diabetes in mice.